AVTR AVANTOR INC
2026Q1 · CUSIP 05352A100 · Sector: Healthcare & Biotech
Neutral · No signal
Holders
427
Δ holders QoQ
+11
Breadth percentile
Top 27%
Whale holders
189
Δ whales
+6
Inst. holding value
$5.3B
New positions
91
Closed positions
80
Price momentum (1Q)
-16.0%
Put / Call
7/7
Breadth history (34 quarters)
Past Lit Events & Aftermath 14 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q2 | Top 17% | -10.8% | -27.4% |
| 2024Q2 | Top 12% | -16.4% | -30.1% |
| 2024Q1 | Top 11% | +1.7% | -17.0% |
| 2023Q4 | Top 16% | +5.2% | +6.9% |
| 2023Q1 | Top 10% | +4.4% | -4.9% |
| 2021Q4 | Top 19% | -14.9% | -23.6% |
| 2021Q3 | Top 3% | -10.3% | -23.7% |
| 2021Q2 | Top 9% | -2.7% | -9.5% |
Options Sentiment
Put holders
7
QoQ: -3
Call holders
7
QoQ: -5
See methodology →
Fundamentals
PE (TTM)
—
EPS (TTM)
$-0.81
EPS YoY
-177.9%
Revenue (TTM)
$6.6B
Revenue YoY
-2.0%
Net margin
-8.4%
ROE
-9.9%
Debt ratio
52.1%
FCF (TTM)
$439M
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.